Electromed (ELMD) Competitors $29.81 +1.16 (+4.05%) (As of 11:27 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends ELMD vs. EYE, BVS, FNA, AVNS, BFLY, IRMD, AXGN, SMLR, SIBN, and KIDSShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include National Vision (EYE), Bioventus (BVS), Paragon 28 (FNA), Avanos Medical (AVNS), Butterfly Network (BFLY), Iradimed (IRMD), AxoGen (AXGN), Semler Scientific (SMLR), SI-BONE (SIBN), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Electromed vs. National Vision Bioventus Paragon 28 Avanos Medical Butterfly Network Iradimed AxoGen Semler Scientific SI-BONE OrthoPediatrics National Vision (NASDAQ:EYE) and Electromed (NYSE:ELMD) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings. Which has better valuation & earnings, EYE or ELMD? Electromed has lower revenue, but higher earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$2.18B0.40-$65.90M-$0.20-54.85Electromed$57.06M4.25$5.15M$0.7239.79 Which has more risk & volatility, EYE or ELMD? National Vision has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Is EYE or ELMD more profitable? Electromed has a net margin of 11.34% compared to National Vision's net margin of -0.81%. Electromed's return on equity of 15.32% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-0.81% 3.52% 1.39% Electromed 11.34%15.32%13.13% Do analysts rate EYE or ELMD? National Vision currently has a consensus target price of $14.00, indicating a potential upside of 27.62%. Given National Vision's stronger consensus rating and higher probable upside, equities analysts clearly believe National Vision is more favorable than Electromed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor EYE or ELMD? National Vision received 241 more outperform votes than Electromed when rated by MarketBeat users. However, 86.67% of users gave Electromed an outperform vote while only 65.63% of users gave National Vision an outperform vote. CompanyUnderperformOutperformNational VisionOutperform Votes25465.63% Underperform Votes13334.37% ElectromedOutperform Votes1386.67% Underperform Votes213.33% Does the media prefer EYE or ELMD? In the previous week, National Vision had 9 more articles in the media than Electromed. MarketBeat recorded 9 mentions for National Vision and 0 mentions for Electromed. National Vision's average media sentiment score of 1.33 beat Electromed's score of 0.00 indicating that National Vision is being referred to more favorably in the media. Company Overall Sentiment National Vision Positive Electromed Neutral Do insiders and institutionals hold more shares of EYE or ELMD? 40.8% of Electromed shares are held by institutional investors. 2.3% of National Vision shares are held by insiders. Comparatively, 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryElectromed beats National Vision on 10 of the 18 factors compared between the two stocks. Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$242.32M$3.14B$5.20B$19.21BDividend YieldN/A1.77%5.12%3.66%P/E Ratio39.7917.1587.0741.07Price / Sales4.2552.731,159.6717.39Price / Cash41.6239.9343.2321.28Price / Book5.563.794.805.31Net Income$5.15M$89.83M$120.46M$989.88M7 Day Performance2.10%0.85%-0.91%-2.50%1 Month Performance-3.83%-0.91%14.91%-4.68%1 Year Performance169.27%0.96%29.59%11.56% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromedN/A$29.81+4.0%N/A+169.3%$252.13M$57.06M41.40174EYENational Vision3.7144 of 5 stars$11.60+1.7%$14.00+20.7%-44.9%$913.50M$2.13B-57.0513,998Positive NewsBVSBioventus3.6159 of 5 stars$11.25+2.0%$16.00+42.2%+103.6%$912.99M$555.06M-18.081,200Positive NewsFNAParagon 283.0831 of 5 stars$10.59+1.6%$15.60+47.3%-19.0%$886.60M$245.00M-14.08343,000AVNSAvanos Medical2.8353 of 5 stars$17.87-0.6%N/A-29.7%$821.31M$673.30M52.853,771BFLYButterfly Network0.6001 of 5 stars$3.55+4.7%$3.00-15.5%+184.9%$756.37M$76.22M-7.37460IRMDIradimed4.5107 of 5 stars$53.44+1.5%$60.00+12.3%+16.7%$677.09M$65.56M36.05110AXGNAxoGen1.0651 of 5 stars$14.39+1.6%$15.00+4.2%+145.6%$633.28M$180.86M-44.47426News CoveragePositive NewsSMLRSemler Scientific1.285 of 5 stars$74.71+11.2%N/A+42.7%$619.35M$68.18M35.2792Gap UpHigh Trading VolumeSIBNSI-BONE4.3217 of 5 stars$13.94+3.9%$23.00+65.0%-37.4%$584.64M$138.89M-14.59350KIDSOrthoPediatrics3.7922 of 5 stars$22.40+1.3%$40.00+78.6%-36.1%$542.53M$148.73M-17.98200 Related Companies and Tools Related Companies EYE Competitors BVS Competitors FNA Competitors AVNS Competitors BFLY Competitors IRMD Competitors AXGN Competitors SMLR Competitors SIBN Competitors KIDS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ELMD) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.